TAT-Gap19 H-IN-AZ1 4-oxadiazol-2-yl]aniline

4-oxadiazol-2-yl]aniline

2-PMPA has neuroprotective activity in an animal model of stroke and anti-allodynic activity in CCI model

3-Dihydrobenzofuran) is an acetylcholinesterase (AChE) inhibitor isolated from leaves of L

mechanism-based inactivator of the trans-cinnamate 4-Hydroxylase

once daily for 4 days) potently inhibits WiDr-induced angiogenesis

TAT-Gap19 H-IN-AZ1 4-oxadiazol-2-yl]anilineTAT Gap19, a Cx mimetic peptide, is a specific connexin43 hemichannel (Cx43 HC) inhibitor. TAT Gap19 does not inhibits the corresponding Cx43 GJCs. TAT Gap19 traverses the blood brain barrier and alleviate liver fibrosis in mice. Product information CAS Number: 1507930 54 2 Molecular Weight: 2703. 25 Formula: C119H212N46O26 Chemical Name: (2S) 6 amino 2 [(2S) 2 [(2S) 6 amino 2 [(2S) 6 amino 2 [(2S,3S) 2 [(2S) 2 [(2S,3S) 2 [(2S) 2 [(2S) 6 amino 2 [(2S)